RAD RADIOPHARM THERANOSTICS Quarterly Activities & Cash Report and 4C for the quarter ended 3 0 June 2026 ASX ANNOUNCEMENT 31 July 2026 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Change in substantial holding
- Target market determination (TMD)
- Prospectus
- Notice Under Section 708A
- Application for quotation of securities - RAD
Later from Radiopharm Theranostics
- Update - Proposed issue of securities - RAD
- Share Purchase Plan - Now Open
- Notice of Extraordinary General Meeting and Proxy Form
- RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
- Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics